Finally, our work challenges these findings with an animal model of ischemic stroke that demonstrate systemic administration of CDNF, by attenuating platelet activation, aggregation responses, and TXA2 production, it therefore mitigates ischemic-induced brain injury and neuroinflammation. This evidence concerns the gene CDNF and ischemic stroke.